Skip to main content

Advertisement

Table 3 Comparison of controller medication adherence at 6 month follow-up by randomization group and by baseline elevated depressive symptoms, for students included in the analysis sample*

From: Exploring the impact of elevated depressive symptoms on the ability of a tailored asthma intervention to improve medication adherence among urban adolescents with asthma

  Treatment Control Adjusted** odds ratio (95% CI) p value
Meet criteria for elevated depressive symptoms at baseline:       
Core behavior at 6 months**       
Controller medication, adherent ≥ 5 of last 7 days 58.3 (7) 12.5 (2) 9.50 (1.35, 67.0) 0.024
Controller medication, not adherent < 5 of last 7 days 41.7 (5) 87.5 (14)   
Do not meet criteria for elevated depressive symptoms at baseline:       
Core behavior at 6 months*       
Controller medication, adherent ≥ 5 of last 7 days 32.6 (15) 30.6 (15) 1.40 (0.53, 3.67) 0.49
Controller medication, not adherent < 5 of last 7 days 67.4 (31) 69.4 (34)   
  1. *Students enrolled in Puff City and reporting a controller medication at baseline assessment. ** Adjusted for controller medication adherence at start of intervention.